Soru

Zorluk: KolayPulmonary and Critical Care

A 6464-year-old man comes to the clinic due to three days of worsening shortness of breath and a productive cough. He has a 4040-pack-year smoking history and was diagnosed with chronic obstructive pulmonary disease (COPD) five years ago. He currently uses a daily tiotropium inhaler and an albuterol inhaler as needed. Over the past three days, he has needed to use his albuterol inhaler every two hours with minimal relief. He also reports that his sputum has increased in volume and changed in color from clear to dark yellow. His temperature is 37.5∘C37.5^\circ\text{C} (99.5∘F99.5^\circ\text{F}), blood pressure is 130/82 mmHg130/82\text{ mmHg}, pulse is 94/min94/\text{min}, and respiratory rate is 22/min22/\text{min}. Pulse oximetry is 93%93\% on room air. Physical examination reveals an increased anteroposterior chest diameter. Lung auscultation shows prolonged expiration with diffuse expiratory wheezing bilaterally. Cardiac examination shows a regular rate and rhythm with no murmurs, gallops, or jugular venous distention. There is no lower extremity edema. Arterial blood gas analysis on room air shows:

pH: 7.387.38
pCO2\text{pCO}_2: 48 mmHg48\text{ mmHg}
pO2\text{pO}_2: 68 mmHg68\text{ mmHg}
HCO3−\text{HCO}_3^-: 27 mEq/L27\text{ mEq/L}

The patient is administered nebulized ipratropium-albuterol and oral prednisone. Which of the following is the most appropriate additional pharmacotherapy for this patient?

  1. Oral azithromycinCevap
  2. B
    Intravenous furosemide
  3. C
    Intravenous piperacillin-tazobactam
  4. D
    Intravenous sodium bicarbonate
  5. E
    Intravenous metoprolol

Cevap

Oral azithromycin
The patient is experiencing an acute exacerbation of chronic obstructive pulmonary disease (AECOPD). The standard treatment bundle for an AECOPD includes short-acting bronchodilators, systemic glucocorticoids, and, when indicated, antibiotics. Antibiotic therapy is specifically indicated in patients who present with all three cardinal symptoms: increased dyspnea, increased sputum volume, and increased sputum purulence (or two symptoms if one is increased purulence). Because this patient exhibits all three, empiric antibiotic therapy targeting common respiratory pathogens (such as Haemophilus influenzae, Streptococcus pneumoniae, and Moraxella catarrhalis) is required. A macrolide (e.g., oral azithromycin), a respiratory fluoroquinolone, or an aminopenicillin is the most appropriate targeted choice for an outpatient or general ward patient.

Adım Adım Çözüm

1
Identify the clinical syndrome presented in the vignette.
The patient has an acute exacerbation of chronic obstructive pulmonary disease (AECOPD), characterized by increased dyspnea, increased sputum volume, and increased sputum purulence.
Recognizing the cardinal symptoms of AECOPD is essential for determining whether antibiotic therapy is indicated.
2
Determine the specific criteria for antibiotic administration in AECOPD.
The patient meets the criteria for antibiotics because he exhibits all three cardinal symptoms.
Antibiotics reduce relapse rates and mortality in patients with moderate-to-severe exacerbations who meet these specific clinical criteria.
3
Select the appropriate pharmacologic agent based on the patient's risk profile.
Oral azithromycin is chosen.
A macrolide provides targeted, narrow-spectrum coverage for the most common bacterial triggers in a patient without risk factors for Pseudomonas aeruginosa.

Anahtar Kavram

Indications for antibiotic therapy in acute exacerbations of chronic obstructive pulmonary disease (AECOPD).
Bu soruyu puanla